Your session is about to expire
← Back to Search
Behavioral Intervention
Health Communication Intervention for HPV Vaccination Hesitancy
N/A
Recruiting
Research Sponsored by Meharry Medical College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will test whether a tailored, health communication intervention can increase HPV vaccination rates among underserved, vaccine hesitant parents.
Who is the study for?
This trial is for parents at Meharry Medical College who previously refused HPV vaccination for their kids aged 11-18, own a smartphone, speak English, and have an upcoming clinic appointment. Healthcare providers involved in primary care to this age group are also eligible. Those with vaccinated children or never offered the vaccine, non-English speakers, and without smartphones or scheduled visits cannot join.Check my eligibility
What is being tested?
The study tests a mobile phone-based web-page intervention designed to educate and encourage HPV vaccine-hesitant parents to vaccinate their adolescents against HPV. It aims to see if tailored health communication before doctor's visits can increase vaccination rates among these families.See study design
What are the potential side effects?
Since the intervention involves educational material rather than medical treatment, there are no direct side effects like those associated with drugs or vaccines. However, participants may experience changes in attitudes towards vaccinations.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Data collection processes
Recruitment Rates
Retention Rates
Secondary outcome measures
HPV vaccine rates
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Mobile Phone-Based Web-Page: HPV vaccineExperimental Treatment1 Intervention
Parents who have already declined the HPV vaccine for their adolescent will receive pre-visit, tailored education information on the HPV vaccine via a text message with a website link.
Group II: Mobile Phone-Based Web-Page: Healthy LifestylesActive Control1 Intervention
Parents who have already declined the HPV vaccine for their adolescent will receive pre-visit education information on an unrelated topic (e.g., healthy eating and physical activity) via a text message with a website link.
Find a Location
Who is running the clinical trial?
Meharry Medical CollegeLead Sponsor
18 Previous Clinical Trials
5,740 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a parent of an 11-18 year old at MMC Pediatrics, refused HPV vaccine before, own a smartphone, speak English, and have an upcoming clinic appointment.I am a healthcare provider for patients aged 11-18.
Research Study Groups:
This trial has the following groups:- Group 1: Mobile Phone-Based Web-Page: HPV vaccine
- Group 2: Mobile Phone-Based Web-Page: Healthy Lifestyles
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Share this study with friends
Copy Link
Messenger